Tiaa, Fsb Adaptive Biotechnologies Corp Transaction History

Tiaa, Fsb

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$7.8 - $10.11 $257 - $333	33 Added 0.14%	23,008 $203,000
Q4 2022 Jan 12, 2023	SELL	$6.26 - $9.34 $25,040 - $37,360	-4,000 Reduced 14.83%	22,975 $176,000
Q3 2022 Oct 11, 2022	SELL	$6.5 - $12.67 $6,500 - $12,670	-1,000 Reduced 3.57%	26,975 $192,000
Q3 2021 Oct 14, 2021	SELL	$30.02 - $39.87 $72,798 - $96,684	-2,425 Reduced 7.98%	27,975 $951,000
Q2 2021 Jul 21, 2021	BUY	$32.22 - $44.59 $979,488 - $1.36 Million	30,400 New	30,400 $1.24 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

Stay updated on Tiaa, Fsb with notifications on news.